Quick Takeaways
- Todd C. Davis has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $56,050,315.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Todd C. Davis
- Location
- La Jolla, CA
- Summary
- The estimated net worth of Todd C. Davis is at least $56,050,315 dollars as of 27 Mar 2026. Todd C. Davis is the Chief Executive Officer, Director of LIGAND PHARMACEUTICALS INC and owns shares of LIGAND PHARMACEUTICALS INC (LGND) stock worth about $37.7M. Todd C. Davis is the Director of Channel Therapeutics Corp and owns shares of Pelthos Therapeutics Inc. (PTHS) stock worth about $16.26M. Todd C. Davis is the Director of PALVELLA THERAPEUTICS, INC. and owns shares of PALVELLA THERAPEUTICS, INC. (PVLA) stock worth about $1.79M. Todd C. Davis is the Director of Vaxart, Inc. and owns shares of Vaxart, Inc. (VXRT) stock worth about $300.9K.
- Signature
- By: /s/ Andrew Reardon, Attorney-in-Fact For: Todd C. Davis
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Todd C. Davis and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: LIGAND PHARMACEUTICALS INC ($37,696,965).
- Past-year value change for that position: +$1,000,456.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Todd C. Davis
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LGND, LGNDZ | LIGAND PHARMACEUTICALS INC | Chief Executive Officer, Director | $37,696,965 | +$1,000,456 | +2.7% | 02 Mar 2026 |
| PTHS | Channel Therapeutics Corp | Director | $16,264,921 | 02 Jul 2025 | ||
| PVLA | PALVELLA THERAPEUTICS, INC. | Director | $1,787,516 | 10 Jun 2025 | ||
| VXRT | Vaxart, Inc. | Director | $300,913 | 04 Aug 2022 | ||
| BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Director | 22 Mar 2022 |
Insider Transactions Reported by Todd C. Davis:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.